ADMA Biologics Inc

The momentum for this stock is not very good. ADMA Biologics Inc is not a good value stock. ADMA Biologics Inc has good growth characteristics. ADMA Biologics Inc is not very popular among insiders. ADMA Biologics Inc is a mediocre stock to choose.
Log in to see more information.
ADMA Biologics, Inc. operates as a biopharmaceutical company. It develops, manufactures, and intends...
ADMA Fundamental Data by TradingView

News

Adma Biologics (ADMA) Recently Broke Out Above the 20-Day Moving Average
Adma Biologics (ADMA) Recently Broke Out Above the 20-Day Moving Average

Zacks Investment Research After reaching an important support level, Adma Biologics (ADMA) could be a good stock pick from a technical perspective. ADMA surpassed resistance at the 20-day moving average, suggesting a...\n more…

ADMA Biologics Inc (ADMA) Hit a 52 Week High, Can the Run Continue?
ADMA Biologics Inc (ADMA) Hit a 52 Week High, Can the Run Continue?

Zacks Investment Research Have you been paying attention to shares of Adma Biologics (ADMA)? Shares have been on the move with the stock up 11.7% over the past month. The stock hit a new 52-week high of $19.34 in the previous...\n more…

What's Going On With ADMA Biologics Stock Monday?
What's Going On With ADMA Biologics Stock Monday?

Benzinga ADMA Biologics shares are moving higher after it was announced that the company will join the S&P SmallCap 600.\n more…

ADMA Biologics, Inc.'s (NASDAQ:ADMA) Intrinsic Value Is Potentially 57% Above Its Share Price
ADMA Biologics, Inc.'s (NASDAQ:ADMA) Intrinsic Value Is Potentially 57% Above Its Share Price

Simply Wall St Key Insights The projected fair value for ADMA Biologics is US$26.20 based on 2 Stage Free Cash Flow to Equity Current...\n more…

Allspring Global Investments Holdings LLC Decreases Stock Position in ADMA Biologics, Inc. (NASDAQ:ADMA)
Allspring Global Investments Holdings LLC Decreases Stock Position in ADMA Biologics, Inc. (NASDAQ:ADMA)

Zolmax Allspring Global Investments Holdings LLC lessened its holdings in ADMA Biologics, Inc. (NASDAQ:ADMA - Free Report) by 16.6% in the 2nd quarter, according to the company in its most recent Form 13F...\n more…

Is ADMA Biologics (ADMA) Outperforming Other Medical Stocks This Year?
Is ADMA Biologics (ADMA) Outperforming Other Medical Stocks This Year?

Zacks Investment Research Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. Is Adma Biologics (ADMA) one of those stocks right now? Let's take a closer look at...\n more…